NPPB and cancer: In a study on 548 treatment-naïve cancer patients, higher resting heart rate was associated with higher NT-proBNP and hs-TnT, and predicted all-cause mortality over a median of 25 months after adjustment for age, gender, tumour type and stage, cardiac status, and haemoglobin (HR for each 5 beats per minute increase 1.10; 95% CI, 1.04–1.16; p < 0.001).